Literature DB >> 6210265

Immunoblotting for determination of the antigenic specificities of antibodies to the Mycoplasmatales.

G E Kenny, F D Cartwright.   

Abstract

Determination of the nature of antigens towards which specific antibodies are directed has caused great difficulties in studies of the antigenic structure of the Mycoplasmatales. In immunoblotting, polypeptides are separated first by SDS polyacrylamide gel electrophoresis and transferred to cellulose nitrate electrophoretically. The resultant pattern is stained by enzyme-linked staining techniques. This permits direct detection of the antigenic specificities recognized by human and animal immune serum. For example, human convalescent sera from patients with Mycoplasma pneumoniae pneumonia recognize 2 to 7 polypeptides in M. pneumoniae, whereas human sera from patients with postpartum fever from whom Ureaplasma urealyticum has been isolated from the bloodstream detect 15 to 25 polypeptides. A comparison of M. pneumoniae with M. genitalium using rabbit antisera demonstrated that these two organisms show strong cross-reactions, although the organisms can be distinguished. Although certain antigens (epitopes) are destroyed in the procedure, it appears that about two-thirds of the polypeptides retain antigenicity. Immunoblotting provides a powerful means for identifying and subsequently fractionating antigens important to the human immune response.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6210265

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  11 in total

1.  Identification of a mycoplasmal protein which binds immunoglobulins nonimmunologically.

Authors:  A G Alexander; H R Lowes; G E Kenny
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Species-specific monoclonal antibody to a 43,000-molecular-weight membrane protein of Mycoplasma pneumoniae.

Authors:  R D Madsen; F A Saeed; O Gray; B M Fendly; S R Coates
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

3.  Reaction pattern of human anti-Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting.

Authors:  E Jacobs; A Bennewitz; W Bredt
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

4.  Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum.

Authors:  M C Roberts; G E Kenny
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

Review 5.  Molecular biology and genetics of mycoplasmas (Mollicutes).

Authors:  S Razin
Journal:  Microbiol Rev       Date:  1985-12

6.  The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period.

Authors:  A C Vu; H M Foy; F D Cartwright; G E Kenny
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

7.  DNA probes for detection and identification of Mycoplasma pneumoniae and Mycoplasma genitalium.

Authors:  H C Hyman; D Yogev; S Razin
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

8.  Production of recombinant antigens of Ureaplasma parvum serotypes 3 and 6 for development of a serological assay.

Authors:  E Vancutsem; F Echahidi; K Van Geel; G Muyldermans; O Soetens; A Naessens
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

9.  Laboratory diagnosis of Mycoplasma pneumoniae infection. 2. Comparison of methods for the direct detection of specific antigen or nucleic acid sequences in respiratory exudates.

Authors:  R Harris; B P Marmion; G Varkanis; T Kok; B Lunn; J Martin
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

10.  A surface epitope undergoing high-frequency phase variation is shared by Mycoplasma gallisepticum and Mycoplasma bovis.

Authors:  D Yogev; D Menaker; K Strutzberg; S Levisohn; H Kirchhoff; K H Hinz; R Rosengarten
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.